Brief: KORU Medical Systems Reports Q4 2021 and Full Year Financial Results
02/03/2022 21:11
March 2 (Reuters) - Repro Med Systems Inc KRMD.O :
* KORU MEDICAL SYSTEMS ANNOUNCES 2021 Q4 AND FULL YEAR
FINANCIAL
RESULTS
* Q4 REVENUE ROSE 60 PERCENT TO $6.5 MILLION
* Q4 ADJUSTED NON-GAAP LOSS PER SHARE $0.02
* EXPECTS OPERATING EXPENSES TO INCREASE TO ROUGHLY $27.0 TO
$28.0
MILLION FOR FULL YEAR 2022
* EXPECTS REVENUE GROWTH IN LOW TO MID DOUBLE DIGITS, OR
$26.0 TO
$27.0 MILLION ON A FULL YEAR BASIS
Source text for Eikon: ID:nBw8qFnkja
Further company coverage: KRMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Koru Medical Systems
See all newsKoru Medical Systems Inc Reports Results For The Quarter Ended June 30: Earnings Summary
KORU Medical Q2 returns to profit on lower manufacturing costs and higher average selling prices
Brief: KORU Medical Systems Q2 Operating Expenses USD 7.2 Million
Koru Medical Systems Inc Expected To Post A Loss Of 2 Cents A Share: Earnings Preview
Brief: Koru Medical Systems - Enters Amendment No. 1 To Supply Agreement With Command Medical Products On June 24, 2026 - SEC Filing